UKRI invites applications for individuals from any discipline wishing to spend up to 36 months (full or part-time) on secondment in the biomedical sciences sector.
UKRI invites applications for individuals from any discipline wishing to spend up to 36 months (full or part time) on secondment in the biomedical sciences sector. Innovate UK are running three identical streams, which open on the same date but have different close dates:
- Strand 1 (this stream) closing 15 April 2020
- Strand 2 closing 13 May 2020
- Strand 3 closing 1 July 2020
You must choose the strand that gives you enough time to complete your application. If you do not submit your application before the close date of one of the earlier streams you will have to re-enter all the information in your application for a later strand.
The objectives of the call are to:
- Create porosity between sectors by enabling career mobility
- Boost the skills, knowledge and career development of people
- Intensify knowledge exchange between the biomedical industry and academia
- Add value to the Biomedical Sciences sector and the UK economy by increasing productivity
Proposals can come from any discipline but either the seconding or host organisation must be a business within the biomedical sciences sector (such as pharmaceutical, biotech, devices, biomedical engineering or diagnostics).
This people-focused competition will achieve its objectives by supporting secondments to fund any activity that enhances the skills of, or provides career development for, the secondee and benefits the organisations involved. The secondee must work on an activity that works towards solving challenges within the secondment (host) environment.
The secondment can be up to 36 months in duration and can be full-time or part-time. The secondment time can be used flexibly over the 36 months. There is no specific minimum but Innovation UK expect the secondment’s duration to be sensible and realistic.
It is expected that the secondment will start by 1 September 2020.
At least one of the organisations involved must be a business undertaking biomedical sciences research and innovation, such as pharmaceutical, biotech, devices, biomedical engineering and/or diagnostics.
Part of the secondment must be based in a facility or laboratory in the UK.
Proposals must be made by the organisation that will receive and control the funds. It is expected this will be the seconding organisation (the normal employer of the secondee).
Due to the nature of these activities it is expected that the seconding and host organisations will collaborate closely on the preparation of the proposal. At least one individual from each organisation involved must be named on the application form.
The seconding organisation can apply for up to £300,000 grant per secondment. There is no minimum request for funding.
During the secondment, the secondee will continue to be employed by the seconding organisation.
Your application must include all costs that the seconding organisation expects UK Research and Innovation (UKRI) to fund. UKRI will only fund the secondee’s:
- Direct salary costs
- National Insurance
- Superannuation (not including bonuses or awards)
- Travel and subsistence costs, including accommodation
The seconding organisation and host are responsible for all costs of hosting the applicant, including training, equipment, consumables and overheads. You must include details of both organisations’ contributions in your application, including any direct financial support and in-kind support to the project.
Secondees must be:
- Resident in the UK
- In employment within their organisation (seconding organisation) for the duration of the proposed project
- Named under the seconding organisation in the application
Where the secondee is the holder of a visa to work, that visa must allow the secondee to undertake the activity proposed. It is the responsibility of the secondee to check with their employer that they are eligible to undertake the activity in line with their visa category and conditions.
This call will not fund international working. The host organisation must have a suitable secondment environment in the UK, although UKRI may fund some international travel if it is justified.
The secondee can be at any career stage. Within academic institutions, UKRI will consider postdoctoral researchers, if they have permission of their supervisor or department to apply. A doctoral qualification is not a requirement, but secondees must have relevant experience within their field. Innovate UK encourage applications from clinically qualified individuals.
This is the organisation sending the secondee.
The seconding organisation must:
- Lead the application and claim grant
- Be ‘research and innovation active’
- Hold a UK bank account
Before activity starts, the host and seconding organisation must provide a draft collaboration agreement and upload it to question 5.
This is the organisation receiving the secondee. The host can not claim grant and must apply as a non grant claiming partner.
Your application must propose a placement within a single host organisation.
Your proposal must show benefit for the host organisation and secondee.
Organisations that agree to host multiple projects must have the resources to support them all if funded.
UKRI application checks
If your application is not in scope or does not fit the eligibility criteria, it will be immediately rejected and will not be sent for assessment.
The Innovation Scholars secondments call has been created to fund activity that would not be possible through other UKRI mechanisms. If UKRI determines that a project would be better supported through another scheme the application may be rejected and redirected. This will be done in consultation with you.
Test for public funding
There must be clearly articulated benefits on both sides of the secondment (the secondee and the organisation they are seconded into as a minimum). If the project could be achieved by paying for a service or by consultancy or a contract it may fail the test for public funding.
UKRI has allocated up to £5million to fund innovation projects across the three streams.
This competition provides state aid funding under article 25, of the General Block Exemption Regulation (GBER). It is your responsibility to make sure your organisation is eligible to receive state aid.
Organisations that are primarily engaged in commercial or economic activity (known as selective advantage) as part of the project must ensure their request for funding does not exceed the limits defined below. This includes organisations that typically act non-economically but for the purpose of this project will be undertaking commercial or economic activity.
For fundamental research projects, you could get funding for your eligible project costs of:
- Up to 100% if you are a micro or small business
- Up to 100% if you are a medium-sized business
- Up to 100% if you are a large business
For feasibility studies and industrial research projects, you could get funding for your eligible project costs of:
- Up to 70% if you are a micro or small business
- Up to 60% if you are a medium-sized business
- Up to 50% if you are a large business
For experimental development projects which are nearer to market, you could get funding for your eligible project costs of:
- Up to 45% if you are a micro or small business
- Up to 35% if you are a medium-sized business
- Up to 25% if you are a large business
The research organisations undertaking non-economic activity as part of this activity can claim up to 100% of the total eligible project costs.
Innovate UK are not funding international working.
Cresco Innovation works with companies to develop and implement innovation strategies. We help client companies identify opportunities to develop new products and services, and then create a package of support to ensure that the idea is turned into a commercial reality.
Our services include securing grants (as a team we have raised around £40million over three years), business planning, IP advice, access to finance and funders, project management and IP commercialisation support.
We regularly act as the interface with the funding bodies and help clients ensure that their projects are properly managed to ensure the best outcome for all.